Point72 Asset Management’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
104,043
-100,659
| -49% | -$1.41M | ﹤0.01% | 900 |
|
|
2025
Q1 | $2.76M | Buy |
+204,702
| New | +$2.76M | 0.01% | 751 |
|
|
2024
Q4 | – | Sell |
-34,627
| Closed | -$788K | – | 1792 |
|
|
2024
Q3 | $788K | Buy |
+34,627
| New | +$788K | ﹤0.01% | 882 |
|
|
2023
Q4 | – | Sell |
-439,191
| Closed | -$6.74M | – | 2134 |
|
|
2023
Q3 | $6.74M | Buy |
+439,191
| New | +$6.74M | 0.02% | 649 |
|
|
2023
Q2 | – | Sell |
-57,100
| Closed | -$1.45M | – | 2205 |
|
|
2023
Q1 | $1.45M | Sell |
57,100
-202,991
| -78% | -$5.16M | ﹤0.01% | 839 |
|
|
2022
Q4 | $7.6M | Sell |
260,091
-26,616
| -9% | -$777K | 0.03% | 563 |
|
|
2022
Q3 | $5.88M | Sell |
286,707
-503,693
| -64% | -$10.3M | 0.02% | 596 |
|
|
2022
Q2 | $9.15M | Buy |
790,400
+490,400
| +163% | +$5.67M | 0.04% | 470 |
|
|
2022
Q1 | $5.55M | Sell |
300,000
-172,864
| -37% | -$3.2M | 0.02% | 615 |
|
|
2021
Q4 | $9.35M | Sell |
472,864
-137,136
| -22% | -$2.71M | 0.04% | 502 |
|
|
2021
Q3 | $10M | Buy |
610,000
+214,466
| +54% | +$3.53M | 0.04% | 458 |
|
|
2021
Q2 | $7.23M | Hold |
395,534
| – | – | 0.03% | 492 |
|
|
2021
Q1 | $6.61M | Sell |
395,534
-30,628
| -7% | -$512K | 0.03% | 497 |
|
|
2020
Q4 | $7.01M | Buy |
+426,162
| New | +$7.01M | 0.03% | 497 |
|
|
2020
Q1 | – | Sell |
-6,646
| Closed | -$48K | – | 1060 |
|
|
2019
Q4 | $48K | Hold |
6,646
| – | – | ﹤0.01% | 856 |
|
|
2019
Q3 | $73K | Hold |
6,646
| – | – | ﹤0.01% | 958 |
|
|
2019
Q2 | $204K | Sell |
6,646
-1,000
| -13% | -$30.7K | ﹤0.01% | 875 |
|
|
2019
Q1 | $320K | Hold |
7,646
| – | – | ﹤0.01% | 804 |
|
|
2018
Q4 | $348K | Sell |
7,646
-16,354
| -68% | -$744K | ﹤0.01% | 785 |
|
|
2018
Q3 | $2.01M | Buy |
+24,000
| New | +$2.01M | 0.01% | 614 |
|